Group One Trading’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$60K Sell
2,400
-900
-27% -$25.4K ﹤0.01% 5121
2025
Q4
$104K Buy
3,300
+900
+38% +$29.8K ﹤0.01% 4976
2025
Q3
$85.7K Buy
2,400
+900
+60% +$41.1K ﹤0.01% 5486
2025
Q2
$86.4K Sell
1,500
-3,100
-67% -$175K ﹤0.01% 5105
2025
Q1
$268K Buy
4,600
+2,300
+100% +$157K ﹤0.01% 3721
2024
Q4
$185K Buy
2,300
+300
+15% +$25.6K ﹤0.01% 3995
2024
Q3
$160K Buy
+2,000
New +$142K ﹤0.01% 3817
2024
Q2
Sell
-300
Closed -$14.8K 7327
2024
Q1
$14.8K Sell
300
-3,500
-92% -$167K ﹤0.01% 5634
2023
Q4
$159K Buy
3,800
+1,200
+46% +$40.9K ﹤0.01% 4063
2023
Q3
$85.3K Buy
+2,600
New +$88.6K ﹤0.01% 4599
2023
Q1
Sell
-20,000
Closed -$831K 7790
2022
Q4
$831K Sell
20,000
-17,300
-46% -$743K ﹤0.01% 2594
2022
Q3
$1.55M Buy
+37,300
New +$1.49M ﹤0.01% 2125

Other funds holding PRCT

Group One Trading's PRCT Position: Q1 2026 in Review

Group One Trading sold out of Procept Biorobotics (PRCT) in Q1 2026, closing a stake of 4,287 shares — an estimated $121K sold.

Group One Trading first reported a position in PRCT in Q4 2023 and held it in 5 quarters. The position peaked at $390K in Q3 2024. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Group One Trading reported no remaining Procept Biorobotics position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 4,287 Procept Biorobotics shares in Q1 2026, an estimated $121K.
  • Group One Trading first reported a position in Procept Biorobotics in Q4 2023 and held it in 5 quarters.
  • Group One Trading's Procept Biorobotics position peaked at $390K in Q3 2024.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.